Interferon-gamma release assay testing to assess COVID-19 vaccination response in a SARS-CoV-2 seronegative patient on rituximab: a case report

International Journal of Infectious Diseases(2021)

引用 0|浏览1
暂无评分
摘要
•A robust T cell response to SARS-CoV-2 vaccination can occur even in patients with impaired humoral immunity.•A delay in immunosuppression may be unnecessary prior to SARS-CoV-2 vaccination.•The known efficacy of SARS-CoV-2 vaccination in immunocompromised patients remains limited.
更多
查看译文
关键词
SARS-CoV-2,SARS-CoV-2 vaccination,T cell respone,Impaired humoral immunity
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要